Structure

Physi-Chem Properties

Molecular Weight:  618.28
Volume:  632.621
LogP:  3.424
LogD:  1.962
LogS:  -2.746
# Rotatable Bonds:  4
TPSA:  154.5
# H-Bond Aceptor:  9
# H-Bond Donor:  4
# Rings:  6
# Heavy Atoms:  9

MedChem Properties

QED Drug-Likeness Score:  0.359
Synthetic Accessibility Score:  5.708
Fsp3:  0.528
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.284
MDCK Permeability:  1.4398605344467796e-05
Pgp-inhibitor:  0.768
Pgp-substrate:  0.999
Human Intestinal Absorption (HIA):  0.053
20% Bioavailability (F20%):  0.9
30% Bioavailability (F30%):  0.088

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.174
Plasma Protein Binding (PPB):  87.67855072021484%
Volume Distribution (VD):  1.259
Pgp-substrate:  9.044248580932617%

ADMET: Metabolism

CYP1A2-inhibitor:  0.006
CYP1A2-substrate:  0.503
CYP2C19-inhibitor:  0.021
CYP2C19-substrate:  0.56
CYP2C9-inhibitor:  0.138
CYP2C9-substrate:  0.116
CYP2D6-inhibitor:  0.005
CYP2D6-substrate:  0.14
CYP3A4-inhibitor:  0.776
CYP3A4-substrate:  0.804

ADMET: Excretion

Clearance (CL):  13.21
Half-life (T1/2):  0.415

ADMET: Toxicity

hERG Blockers:  0.367
Human Hepatotoxicity (H-HT):  0.409
Drug-inuced Liver Injury (DILI):  0.278
AMES Toxicity:  0.012
Rat Oral Acute Toxicity:  0.958
Maximum Recommended Daily Dose:  0.992
Skin Sensitization:  0.406
Carcinogencity:  0.861
Eye Corrosion:  0.003
Eye Irritation:  0.011
Respiratory Toxicity:  0.987

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC85047

Natural Product ID:  NPC85047
Common Name*:   Dichrostachine B
IUPAC Name:   (4aR,8R,8aS)-8-[[(1R,3S,4aS,7S,8aS)-3,7-dihydroxy-5,5,8a-trimethyl-2-methylidene-3,4,4a,6,7,8-hexahydro-1H-naphthalen-1-yl]methyl]-8a-(5,7-dihydroxy-4-oxochromen-2-yl)-3-methoxy-7-methyl-5,8-dihydro-4aH-naphthalene-1,4-dione
Synonyms:  
Standard InCHIKey:  DYFMUBBDBHDXDV-QUUXZHRUSA-N
Standard InCHI:  InChI=1S/C36H42O9/c1-17-7-8-21-33(43)28(44-6)14-30(42)36(21,31-13-26(41)32-25(40)9-19(37)10-27(32)45-31)22(17)11-23-18(2)24(39)12-29-34(3,4)15-20(38)16-35(23,29)5/h7,9-10,13-14,20-24,29,37-40H,2,8,11-12,15-16H2,1,3-6H3/t20-,21-,22+,23-,24-,29-,35+,36-/m0/s1
SMILES:  CC1=CC[C@H]2C(=O)C(=CC(=O)[C@]2([C@@H]1C[C@H]1C(=C)[C@H](C[C@H]2C(C)(C)C[C@@H](C[C@]12C)O)O)c1cc(=O)c2c(cc(cc2o1)O)O)OC
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL1077605
PubChem CID:   44557089
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001551] Diterpenoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO15669 Dichrostachys cinerea Species Fabaceae Eukaryota n.a. n.a. n.a. PMID[19761234]
NPO15669 Dichrostachys cinerea Species Fabaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT2 Others Unspecified IC50 = 40000.0 nM PMID[508181]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. Activity > 10.0 uM PMID[508181]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC85047 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC17274
1.0 High Similarity NPC120857
0.9873 High Similarity NPC286074
0.9873 High Similarity NPC20734
0.9873 High Similarity NPC54903
0.9811 High Similarity NPC193698
0.9744 High Similarity NPC103816
0.9744 High Similarity NPC61382
0.9689 High Similarity NPC469393
0.962 High Similarity NPC469395
0.9379 High Similarity NPC469394
0.908 High Similarity NPC316262
0.908 High Similarity NPC314653
0.8976 High Similarity NPC315306
0.8976 High Similarity NPC313717
0.8957 High Similarity NPC475106
0.8951 High Similarity NPC472618
0.8931 High Similarity NPC470353
0.8889 High Similarity NPC472617
0.8882 High Similarity NPC470354
0.8882 High Similarity NPC192587
0.8882 High Similarity NPC470352
0.8846 High Similarity NPC472447
0.8846 High Similarity NPC472446
0.8834 High Similarity NPC195136
0.8834 High Similarity NPC313368
0.8795 High Similarity NPC476255
0.8782 High Similarity NPC473812
0.8782 High Similarity NPC473813
0.8773 High Similarity NPC105584
0.8773 High Similarity NPC15815
0.8773 High Similarity NPC90497
0.8765 High Similarity NPC54830
0.8765 High Similarity NPC56049
0.8757 High Similarity NPC471969
0.8757 High Similarity NPC475080
0.8743 High Similarity NPC223413
0.8743 High Similarity NPC193222
0.8712 High Similarity NPC474637
0.8712 High Similarity NPC257166
0.8698 High Similarity NPC476159
0.8698 High Similarity NPC118128
0.8698 High Similarity NPC477529
0.8696 High Similarity NPC154683
0.8696 High Similarity NPC40356
0.8683 High Similarity NPC476056
0.8683 High Similarity NPC125465
0.8683 High Similarity NPC251336
0.8679 High Similarity NPC470460
0.8675 High Similarity NPC100849
0.8659 High Similarity NPC51247
0.8659 High Similarity NPC295090
0.8659 High Similarity NPC125969
0.8655 High Similarity NPC98943
0.8655 High Similarity NPC469345
0.8647 High Similarity NPC154986
0.8642 High Similarity NPC155686
0.8642 High Similarity NPC193200
0.8634 High Similarity NPC178484
0.8634 High Similarity NPC470675
0.8634 High Similarity NPC305965
0.8634 High Similarity NPC473131
0.8634 High Similarity NPC46882
0.8634 High Similarity NPC132990
0.8634 High Similarity NPC470569
0.8631 High Similarity NPC105414
0.8631 High Similarity NPC470341
0.8631 High Similarity NPC234497
0.8631 High Similarity NPC472058
0.8631 High Similarity NPC324522
0.8625 High Similarity NPC470461
0.8623 High Similarity NPC469664
0.8623 High Similarity NPC472049
0.8614 High Similarity NPC94796
0.8614 High Similarity NPC473022
0.8606 High Similarity NPC98023
0.8606 High Similarity NPC475107
0.8606 High Similarity NPC121647
0.8606 High Similarity NPC226462
0.8606 High Similarity NPC43490
0.8605 High Similarity NPC476199
0.8605 High Similarity NPC476210
0.8599 High Similarity NPC204469
0.8598 High Similarity NPC271741
0.8598 High Similarity NPC281137
0.8598 High Similarity NPC208258
0.8598 High Similarity NPC272196
0.8598 High Similarity NPC287789
0.8598 High Similarity NPC282390
0.8598 High Similarity NPC1796
0.8598 High Similarity NPC201127
0.8596 High Similarity NPC86809
0.8596 High Similarity NPC232412
0.8596 High Similarity NPC294149
0.8596 High Similarity NPC475398
0.8596 High Similarity NPC98667
0.8589 High Similarity NPC79375
0.8589 High Similarity NPC37253
0.8588 High Similarity NPC169018
0.858 High Similarity NPC473770
0.858 High Similarity NPC473509
0.858 High Similarity NPC475131
0.858 High Similarity NPC470340
0.858 High Similarity NPC43345
0.858 High Similarity NPC102810
0.858 High Similarity NPC63514
0.8571 High Similarity NPC62444
0.8571 High Similarity NPC197972
0.8571 High Similarity NPC188403
0.8571 High Similarity NPC61258
0.8571 High Similarity NPC470568
0.8563 High Similarity NPC476295
0.8563 High Similarity NPC290160
0.8563 High Similarity NPC131578
0.8555 High Similarity NPC473729
0.8555 High Similarity NPC473607
0.8554 High Similarity NPC476929
0.8553 High Similarity NPC470458
0.8547 High Similarity NPC227275
0.8538 High Similarity NPC470333
0.8538 High Similarity NPC476311
0.8537 High Similarity NPC469507
0.8537 High Similarity NPC164427
0.8537 High Similarity NPC32867
0.8537 High Similarity NPC198489
0.8537 High Similarity NPC309648
0.8537 High Similarity NPC61112
0.8529 High Similarity NPC476196
0.8528 High Similarity NPC121568
0.8528 High Similarity NPC214632
0.8528 High Similarity NPC324447
0.8521 High Similarity NPC470377
0.8521 High Similarity NPC472622
0.8521 High Similarity NPC471975
0.8521 High Similarity NPC470374
0.8521 High Similarity NPC76647
0.8521 High Similarity NPC478059
0.8521 High Similarity NPC478060
0.8519 High Similarity NPC476551
0.8519 High Similarity NPC476553
0.8519 High Similarity NPC476552
0.8519 High Similarity NPC478148
0.8512 High Similarity NPC472051
0.8512 High Similarity NPC472057
0.8509 High Similarity NPC471114
0.8509 High Similarity NPC146014
0.8506 High Similarity NPC208069
0.8503 High Similarity NPC472059
0.8503 High Similarity NPC473012
0.85 High Similarity NPC10990
0.85 High Similarity NPC259632
0.85 High Similarity NPC300988
0.8497 Intermediate Similarity NPC233978
0.8497 Intermediate Similarity NPC477683
0.8497 Intermediate Similarity NPC477682
0.8494 Intermediate Similarity NPC42965
0.8494 Intermediate Similarity NPC286422
0.8491 Intermediate Similarity NPC476055
0.8491 Intermediate Similarity NPC470673
0.8491 Intermediate Similarity NPC117716
0.8491 Intermediate Similarity NPC224714
0.8491 Intermediate Similarity NPC470674
0.8488 Intermediate Similarity NPC477991
0.8488 Intermediate Similarity NPC477992
0.8485 Intermediate Similarity NPC475184
0.8481 Intermediate Similarity NPC325346
0.8481 Intermediate Similarity NPC277369
0.8481 Intermediate Similarity NPC215451
0.848 Intermediate Similarity NPC472620
0.8476 Intermediate Similarity NPC258474
0.8476 Intermediate Similarity NPC201227
0.8476 Intermediate Similarity NPC304745
0.8476 Intermediate Similarity NPC68727
0.8476 Intermediate Similarity NPC111341
0.8471 Intermediate Similarity NPC472619
0.8471 Intermediate Similarity NPC41598
0.8471 Intermediate Similarity NPC75141
0.8471 Intermediate Similarity NPC476146
0.8471 Intermediate Similarity NPC158329
0.8471 Intermediate Similarity NPC47634
0.8471 Intermediate Similarity NPC188079
0.8471 Intermediate Similarity NPC40089
0.8471 Intermediate Similarity NPC476216
0.8471 Intermediate Similarity NPC55422
0.8466 Intermediate Similarity NPC113608
0.8466 Intermediate Similarity NPC180944
0.8466 Intermediate Similarity NPC87708
0.8466 Intermediate Similarity NPC268992
0.8466 Intermediate Similarity NPC174086
0.8466 Intermediate Similarity NPC470337
0.8466 Intermediate Similarity NPC470338
0.8466 Intermediate Similarity NPC51824
0.8462 Intermediate Similarity NPC475109
0.8462 Intermediate Similarity NPC25427
0.8462 Intermediate Similarity NPC472621
0.8457 Intermediate Similarity NPC29777
0.8457 Intermediate Similarity NPC255641
0.8457 Intermediate Similarity NPC290954
0.8457 Intermediate Similarity NPC147735
0.8457 Intermediate Similarity NPC471115

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC85047 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8589 High Similarity NPD8443 Clinical (unspecified phase)
0.8375 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.8373 Intermediate Similarity NPD7075 Discontinued
0.8363 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.8333 Intermediate Similarity NPD6959 Discontinued
0.8303 Intermediate Similarity NPD7819 Suspended
0.8261 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.8242 Intermediate Similarity NPD6801 Discontinued
0.8232 Intermediate Similarity NPD4380 Phase 2
0.8193 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.8187 Intermediate Similarity NPD6166 Phase 2
0.8187 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.8187 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.8121 Intermediate Similarity NPD6599 Discontinued
0.8113 Intermediate Similarity NPD1549 Phase 2
0.8101 Intermediate Similarity NPD2796 Approved
0.8081 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.8072 Intermediate Similarity NPD7411 Suspended
0.8068 Intermediate Similarity NPD7808 Phase 3
0.805 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.805 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.8047 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.8038 Intermediate Similarity NPD1510 Phase 2
0.8011 Intermediate Similarity NPD7251 Discontinued
0.8011 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7988 Intermediate Similarity NPD3882 Suspended
0.7988 Intermediate Similarity NPD7768 Phase 2
0.7976 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7955 Intermediate Similarity NPD6797 Phase 2
0.795 Intermediate Similarity NPD2800 Approved
0.7939 Intermediate Similarity NPD5403 Approved
0.7931 Intermediate Similarity NPD7473 Discontinued
0.7929 Intermediate Similarity NPD5402 Approved
0.7911 Intermediate Similarity NPD6651 Approved
0.7901 Intermediate Similarity NPD3750 Approved
0.7889 Intermediate Similarity NPD8434 Phase 2
0.7888 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7875 Intermediate Similarity NPD6100 Approved
0.7875 Intermediate Similarity NPD6099 Approved
0.7866 Intermediate Similarity NPD6799 Approved
0.7853 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7841 Intermediate Similarity NPD7054 Approved
0.7824 Intermediate Similarity NPD3817 Phase 2
0.7818 Intermediate Similarity NPD5401 Approved
0.7811 Intermediate Similarity NPD1934 Approved
0.7799 Intermediate Similarity NPD1607 Approved
0.7797 Intermediate Similarity NPD7472 Approved
0.7797 Intermediate Similarity NPD7074 Phase 3
0.7791 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7785 Intermediate Similarity NPD1240 Approved
0.7784 Intermediate Similarity NPD3818 Discontinued
0.7778 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7771 Intermediate Similarity NPD1512 Approved
0.7765 Intermediate Similarity NPD2801 Approved
0.7765 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7759 Intermediate Similarity NPD6232 Discontinued
0.7746 Intermediate Similarity NPD5494 Approved
0.7733 Intermediate Similarity NPD3749 Approved
0.7711 Intermediate Similarity NPD2534 Approved
0.7711 Intermediate Similarity NPD2532 Approved
0.7711 Intermediate Similarity NPD2533 Approved
0.7702 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7692 Intermediate Similarity NPD8150 Discontinued
0.7684 Intermediate Similarity NPD3751 Discontinued
0.7651 Intermediate Similarity NPD1511 Approved
0.7647 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.764 Intermediate Similarity NPD5844 Phase 1
0.7633 Intermediate Similarity NPD3226 Approved
0.7624 Intermediate Similarity NPD8312 Approved
0.7624 Intermediate Similarity NPD8313 Approved
0.7593 Intermediate Similarity NPD3748 Approved
0.7576 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7576 Intermediate Similarity NPD4628 Phase 3
0.7558 Intermediate Similarity NPD5761 Phase 2
0.7558 Intermediate Similarity NPD5760 Phase 2
0.7545 Intermediate Similarity NPD7390 Discontinued
0.7515 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7514 Intermediate Similarity NPD6559 Discontinued
0.7514 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD7698 Approved
0.75 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD7696 Phase 3
0.75 Intermediate Similarity NPD7697 Approved
0.75 Intermediate Similarity NPD7435 Discontinued
0.7486 Intermediate Similarity NPD5537 Clinical (unspecified phase)
0.7473 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7461 Intermediate Similarity NPD7870 Phase 2
0.7461 Intermediate Similarity NPD7871 Phase 2
0.7459 Intermediate Similarity NPD5953 Discontinued
0.7439 Intermediate Similarity NPD1551 Phase 2
0.7438 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.7435 Intermediate Similarity NPD6782 Approved
0.7435 Intermediate Similarity NPD6779 Approved
0.7435 Intermediate Similarity NPD6780 Approved
0.7435 Intermediate Similarity NPD6781 Approved
0.7435 Intermediate Similarity NPD6776 Approved
0.7435 Intermediate Similarity NPD6777 Approved
0.7435 Intermediate Similarity NPD6778 Approved
0.7427 Intermediate Similarity NPD7458 Discontinued
0.7416 Intermediate Similarity NPD3926 Phase 2
0.7398 Intermediate Similarity NPD8151 Discontinued
0.7394 Intermediate Similarity NPD2344 Approved
0.7378 Intermediate Similarity NPD2799 Discontinued
0.736 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.736 Intermediate Similarity NPD7874 Approved
0.736 Intermediate Similarity NPD3787 Discontinued
0.7353 Intermediate Similarity NPD6273 Approved
0.7351 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7347 Intermediate Similarity NPD7701 Phase 2
0.7329 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7329 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7326 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7323 Intermediate Similarity NPD7801 Approved
0.7312 Intermediate Similarity NPD4908 Phase 1
0.731 Intermediate Similarity NPD920 Approved
0.7305 Intermediate Similarity NPD1243 Approved
0.7303 Intermediate Similarity NPD1247 Approved
0.7289 Intermediate Similarity NPD1471 Phase 3
0.7288 Intermediate Similarity NPD919 Approved
0.7282 Intermediate Similarity NPD8320 Phase 1
0.7282 Intermediate Similarity NPD8319 Approved
0.7263 Intermediate Similarity NPD4360 Phase 2
0.7263 Intermediate Similarity NPD4363 Phase 3
0.7262 Intermediate Similarity NPD7003 Approved
0.7257 Intermediate Similarity NPD1465 Phase 2
0.7253 Intermediate Similarity NPD7286 Phase 2
0.724 Intermediate Similarity NPD7699 Phase 2
0.724 Intermediate Similarity NPD7700 Phase 2
0.7229 Intermediate Similarity NPD2935 Discontinued
0.7219 Intermediate Similarity NPD2309 Approved
0.7207 Intermediate Similarity NPD8127 Discontinued
0.72 Intermediate Similarity NPD37 Approved
0.7198 Intermediate Similarity NPD7228 Approved
0.7193 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7188 Intermediate Similarity NPD6917 Clinical (unspecified phase)
0.7186 Intermediate Similarity NPD2346 Discontinued
0.7182 Intermediate Similarity NPD7784 Clinical (unspecified phase)
0.7176 Intermediate Similarity NPD7236 Approved
0.7176 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7175 Intermediate Similarity NPD4967 Phase 2
0.7175 Intermediate Similarity NPD4966 Approved
0.7175 Intermediate Similarity NPD4965 Approved
0.7173 Intermediate Similarity NPD6534 Approved
0.7173 Intermediate Similarity NPD6535 Approved
0.7167 Intermediate Similarity NPD5710 Approved
0.7167 Intermediate Similarity NPD5711 Approved
0.716 Intermediate Similarity NPD8166 Discontinued
0.7127 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7125 Intermediate Similarity NPD1470 Approved
0.7117 Intermediate Similarity NPD2313 Discontinued
0.7099 Intermediate Similarity NPD6832 Phase 2
0.7095 Intermediate Similarity NPD6234 Discontinued
0.7091 Intermediate Similarity NPD5124 Phase 1
0.7091 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7088 Intermediate Similarity NPD2403 Approved
0.7081 Intermediate Similarity NPD2798 Approved
0.7077 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7072 Intermediate Similarity NPD7229 Phase 3
0.7069 Intermediate Similarity NPD7239 Suspended
0.7066 Intermediate Similarity NPD7033 Discontinued
0.7065 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7065 Intermediate Similarity NPD7783 Phase 2
0.7047 Intermediate Similarity NPD4362 Clinical (unspecified phase)
0.7047 Intermediate Similarity NPD4361 Phase 2
0.703 Intermediate Similarity NPD943 Approved
0.7022 Intermediate Similarity NPD4288 Approved
0.7017 Intermediate Similarity NPD7199 Phase 2
0.7012 Intermediate Similarity NPD3268 Approved
0.7011 Intermediate Similarity NPD7799 Discontinued
0.7011 Intermediate Similarity NPD7893 Clinical (unspecified phase)
0.7006 Intermediate Similarity NPD6844 Discontinued
0.7005 Intermediate Similarity NPD7907 Approved
0.7005 Intermediate Similarity NPD6823 Phase 2
0.7005 Intermediate Similarity NPD8366 Approved
0.7005 Intermediate Similarity NPD8155 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD4749 Approved
0.6988 Remote Similarity NPD6355 Discontinued
0.6981 Remote Similarity NPD1547 Clinical (unspecified phase)
0.6981 Remote Similarity NPD1610 Phase 2
0.6966 Remote Similarity NPD8455 Phase 2
0.6964 Remote Similarity NPD651 Clinical (unspecified phase)
0.6952 Remote Similarity NPD6765 Approved
0.6952 Remote Similarity NPD6764 Approved
0.695 Remote Similarity NPD7584 Approved
0.6949 Remote Similarity NPD7615 Clinical (unspecified phase)
0.6939 Remote Similarity NPD8285 Discontinued
0.6937 Remote Similarity NPD3972 Approved
0.6923 Remote Similarity NPD5408 Approved
0.6923 Remote Similarity NPD5404 Approved
0.6923 Remote Similarity NPD5406 Approved
0.6923 Remote Similarity NPD5405 Approved
0.6919 Remote Similarity NPD6190 Approved
0.6914 Remote Similarity NPD6980 Clinical (unspecified phase)
0.6914 Remote Similarity NPD2797 Approved
0.6914 Remote Similarity NPD1203 Approved
0.6909 Remote Similarity NPD6798 Discontinued
0.6897 Remote Similarity NPD7422 Clinical (unspecified phase)
0.6893 Remote Similarity NPD8404 Phase 2
0.6886 Remote Similarity NPD230 Phase 1
0.6875 Remote Similarity NPD1201 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data